Trade Novo Nordisk Stock – Innovating Care in Diabetes and Chronic Diseases

Novo Nordisk A/S (NYSE: NVO) is a global leader in diabetes care and chronic disease treatment, based in Denmark. The company is widely recognized for its breakthrough GLP-1 therapies such as Ozempic and Wegovy, used for diabetes and weight management. Traded under the symbol NVO, it operates in the healthcare sector and is a top stock for investors tracking innovation in metabolic and endocrine therapies.